PERORAL MEDICAL PRODUCT FOR OFFSET OF MAGNESIUM DEFICIENCY IN ORGANISM

FIELD: medicine; pharmacology. ^ SUBSTANCE: invention concerns medical product for metabolic regulation associated with magnesium deficiency in organism. Medical product is solid dosage form containing magnesium di-(L-asparaginate) in amount 200 to 1000 mg and pyridoxine hydrochloride in amount 2 to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SINOLITSKAJA STEHLLA VLADIMIROVNA, SINOLITSKIJ MAKSIM KONSTANTINOVICH, SPASOV ALEKSANDR ALEKSEEVICH, IEZHITSA IGOR' NIKOLAEVICH, VORONIN SERGEJ PETROVICH, PETROV VLADIMIR IVANOVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine; pharmacology. ^ SUBSTANCE: invention concerns medical product for metabolic regulation associated with magnesium deficiency in organism. Medical product is solid dosage form containing magnesium di-(L-asparaginate) in amount 200 to 1000 mg and pyridoxine hydrochloride in amount 2 to 20 mg per unit dose (magnesium di-(L-asparaginate) and pyridoxine hydrochloride in weight ratio 50:1 to 200:1). ^ EFFECT: medical product provides high ion bioavailability and decreased excretory system burden. ^ 8 cl, 5 ex, 3 tbl